Legend Capital co-leads $293m round in Chinese Diagnostics Medical Corp

Legend Capital co-leads $293m round in Chinese Diagnostics Medical Corp

An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S., on Wednesday, Feb. 8, 2012. Photographer: David Paul Morris/Bloomberg

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter